Published in Hepatology on September 01, 2006
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med (2009) 3.70
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet (2012) 1.85
The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology (2011) 1.51
Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun (2007) 1.36
Update on primary biliary cirrhosis. Dig Liver Dis (2010) 1.08
Pathogenesis of primary biliary cirrhosis. Gut (2007) 1.05
Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving. Hepatology (2011) 0.99
Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol (2008) 0.96
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. Genes Immun (2012) 0.91
Genome-Wide Association Studies in Primary Biliary Cirrhosis. Semin Liver Dis (2015) 0.90
Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS One (2013) 0.90
Primary biliary cirrhosis: family stories. Autoimmune Dis (2011) 0.89
Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS One (2014) 0.89
Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol (2014) 0.89
Update on the genetics and genomics of PBC. J Autoimmun (2010) 0.88
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet (2009) 0.87
Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol (2010) 0.86
Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis (2008) 0.86
The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology (2008) 0.85
Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk. J Immunol (2013) 0.82
Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol (2011) 0.82
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol (2011) 0.81
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Auto Immun Highlights (2010) 0.81
Cirrhosis and autoimmune liver disease: Current understanding. World J Hepatol (2016) 0.81
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights (2011) 0.79
Genome-wide association studies--a summary for the clinical gastroenterologist. World J Gastroenterol (2009) 0.78
Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis. PLoS One (2013) 0.78
The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk. Genes Immun (2015) 0.77
Familial clustering and genetic background of primary biliary cirrhosis in Japan. Dig Dis Sci (2009) 0.77
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis. J Immunol Res (2017) 0.75
Primary biliary cirrhosis and liver transplantation. Intractable Rare Dis Res (2012) 0.75
Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol (2015) 0.75
Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia. United European Gastroenterol J (2016) 0.75
Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ (2009) 3.20
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol (2006) 2.88
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol (2006) 2.64
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59
Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology (2012) 2.47
Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology (2007) 2.21
Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest (2007) 2.01
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology (2012) 2.01
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology (2002) 1.98
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet (2012) 1.85
The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology (2002) 1.84
Liver disease in pregnancy. Lancet (2010) 1.84
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut (2011) 1.81
Gender medicine: a task for the third millennium. Clin Chem Lab Med (2013) 1.78
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77
Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol (2006) 1.58
Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. Infect Control Hosp Epidemiol (2002) 1.52
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis. Liver Int (2006) 1.51
Mortality and recovery after stroke in the Gambia. Stroke (2003) 1.50
Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology (2009) 1.50
Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Virol (2008) 1.48
Seasonal variation in the patient diagnosis of primary biliary cirrhosis: further evidence for an environmental component to etiology. Hepatology (2011) 1.48
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity. J Hepatol (2012) 1.47
Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45
Making sense of fatigue. Occup Med (Lond) (2010) 1.44
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology (2006) 1.37
Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem (2006) 1.35
Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25
Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis. Clin Gastroenterol Hepatol (2008) 1.12
Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol (2007) 1.12
Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol (2008) 1.11
Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology (2010) 1.11
The epidemiology of primary biliary cirrhosis. Clin Liver Dis (2003) 1.09
Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand. Hepatology (2013) 1.09
Transjugular biopsy of the liver in pediatric and adult patients using an 18-gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures. AJR Am J Roentgenol (2003) 1.08
Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. J Gen Virol (2004) 1.08
Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology (2013) 1.07
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl (2010) 1.05
Characterization of hepatitis C RNA-containing particles from human liver by density and size. J Gen Virol (2008) 1.03
Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology (2009) 1.01
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol (2006) 1.00
Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest (2010) 1.00
Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol (2008) 1.00
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl (2008) 0.99
Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med (2008) 0.99
Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol (2007) 0.99
Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2007) 0.99
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98
Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology (2010) 0.98
Capability and dependency in the Newcastle 85+ cohort study. Projections of future care needs. BMC Geriatr (2011) 0.97
Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration. Liver Transpl (2008) 0.94
Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol (2007) 0.94
Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res (2009) 0.94
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. Clin Dev Immunol (2010) 0.94
Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J Am Geriatr Soc (2006) 0.93
Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology (2007) 0.93
Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management. Dig Dis (2015) 0.93
Primary biliary cirrhosis: report of a focus study group. Hepatology (2004) 0.92
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection. Immunology (2004) 0.92
Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun (2013) 0.92
Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand (2002) 0.91
Epidemiological aspect of traumatic brain injury in Northeast Italy. Eur J Epidemiol (2003) 0.90
Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol (2009) 0.90
Lower ambulatory blood pressure in chronic fatigue syndrome. Psychosom Med (2009) 0.90
Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. Am J Gastroenterol (2002) 0.90
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs). Clin Res Hepatol Gastroenterol (2012) 0.89
Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int (2006) 0.88
Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology (2004) 0.88
Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology (2009) 0.87
Assessing quality of life in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2004) 0.87
Fatigue in primary biliary cirrhosis. BMJ (2012) 0.87
Intrafamilial transmission of hepatitis C virus infection. Eur J Epidemiol (2006) 0.87
Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology (2003) 0.86
Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2003) 0.85
Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology (2003) 0.85